Single-cell characterisation of tissue homing CD4 + and CD8 + T cell clones in immune-mediated refractory arthritis
Description
Abstract Background Immune-mediated arthritis is a group of autoinflammatory diseases, where the patient’s own immune system attacks and destroys synovial joints. Sustained remission is not always achieved with available immunosuppressive treatments, warranting more detailed studies of T cell responses that perpetuate synovial inflammation in treatment-refractory patients. Methods In this study, we investigated CD4 + and CD8 + T lymphocytes from the synovial tissue and peripheral blood of patients with treatment-resistant immune-mediated arthritis using paired single-cell RNA and TCR-sequencing. To gain insights into the trafficking of clonal families, we compared the phenotypes of clones with the exact same TCRß amino acid sequence between the two tissues. Results Our results show that both CD4 + and CD8 + T cells display a more activated and inflamed phenotype in the synovial tissue compared to peripheral blood both at the population level and within individual T cell families. Furthermore, we found that both cell subtypes exhibited clonal expansion in the synovial tissue. Conclusions Our findings suggest that the local environment in the synovium drives the proliferation of activated cytotoxic T cells, and both CD4 + and CD8 + T cells may contribute to tissue destruction and disease pathogenesis.
Show moreYear of publication
2024
Authors
Department of Computer Science
Dipabarna Bhattacharya - Creator
Jason Theodoropoulos - Creator
Kari K. Eklund - Creator
Katariina Nurmi - Creator
Riitta Koivuniemi - Creator
Satu Mustjoki - Creator
Tapio Lönnberg - Creator
Tiina Kelkka - Creator
Timo Juutilainen - Creator
Helsinki University Hospital - Contributor
University of Helsinki - Contributor
University of Turku - Contributor
figshare - Publisher
Other information
Fields of science
General medicine, internal medicine and other clinical medicine
Open access
Open
License
Creative Commons Attribution 4.0 International (CC BY 4.0)